Ophthalmology

Adverse Events

Questions discussed in this category

How should Dato-DXd be managed in the absence of necessary resources for ocular exams and referrals?

What is the ideal timing and frequency of referrals for exams? What is the bare minimum if access is limited?

3 Answers available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Sep 12

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.

Cancer treatment reviews, 2024 Mar 11

Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.

Related Topics in Ophthalmology